Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/46947

Registo completo
Campo DCValorIdioma
dc.contributor.authorDuarte, Ana Rita C.por
dc.contributor.authorFerreira, Ana S. D.por
dc.contributor.authorBarreiros, Susanapor
dc.contributor.authorCabrita, Euricopor
dc.contributor.authorReis, R. L.por
dc.contributor.authorPaiva, Alexandrepor
dc.date.accessioned2017-10-31T18:32:46Z-
dc.date.available2017-10-31T18:32:46Z-
dc.date.issued2017-02-
dc.date.submitted2017-02-
dc.identifier.citationDuarte A. R. C., Ferreira A. S. D., Barreiros S., Cabrita E., Reis R. L., Paiva A. A comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: Solubility and permeability studies, European Journal Of Pharmaceutics And Biopharmaceutics, Vol. 114, pp. 296-304, doi:10.1016/j.ejpb.2017.02.003, 2017por
dc.identifier.issn0939-6411por
dc.identifier.urihttps://hdl.handle.net/1822/46947-
dc.description.abstractTHEDES, so called therapeutic deep eutectic solvents are here defined as a mixture of two components, which at a particular molar composition become liquid at room temperature and in which one of them is an active pharmaceutical ingredient (API). In this work, THEDES based on menthol complexed with three different APIs, ibuprofen (ibu), BA (BA) and phenylacetic acid (PA), were prepared. The interactions between the components that constitute the THEDES were studied by NMR, confirming that the eutectic system is formed by H-bonds between menthol and the API. The mobility of the THEDES components was studied by PFGSE NMR spectroscopy. It was determined that the self-diffusion of the species followed the same behavior as observed previously for ionic liquids, in which the components migrate via jumping between voids in the suprastructure created by punctual thermal fluctuations. The solubility and permeability of the systems in an isotonic solution was evaluated and a comparison with the pure APIs was established through diffusion and permeability studies carried out in a Franz cell. The solubility of the APIs when in the THEDES system can be improved up to 12 fold, namely for the system containing ibu. Furthermore, for this system the permeability was calculated to be 14 105 cm/s representing a 3 fold increase in comparison with the pure API. With the exception of the systems containing PA an increase in the solubility, coupled with an increase in permeability was observed. In this work, we hence demonstrate the efficiency of THEDES as a new formulation for the enhancement of the bioavailability of APIs by changing the physical state of the molecules from a solid dosage to a liquid system.por
dc.description.sponsorshiphe European Union’s Seventh Framework Programme (FP7/2007- 2013) under grant agreement nREGPOT-CT2012-316331- POLARIS and from Project ‘‘Novel smart and biomimetic materials for innovative regenerative medicine approaches (Ref.: RL1 - ABMR - NORTE-01-0124-FEDER-000016)” co-financed by North Portugal Regional Operational Programme (ON.2 – O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). Funding was also provided by Fundação para a Ciência e a Tecnologia, through contracts LAQV-REQUIMTE: UID/QUI/50006/2013 and UCIBIOREQUIMTE: UID/Multi/04378/2013. This work was co-financed by the ERDF under the PT2020 Partnership Agreement (POCI-01- 0145-FEDER-007728).por
dc.language.isoengpor
dc.publisherElsevier B.V.por
dc.relationinfo:eu-repo/grantAgreement/EC/FP7/316331/EUpor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147218/PTpor
dc.relationinfo:eu-repo/grantAgreement/FCT/5876/147258/PTpor
dc.rightsopenAccesspor
dc.subjectDiffusion coefficientpor
dc.subjectDrug solubilitypor
dc.subjectPermeabilitypor
dc.subjectPharmaceutical and biomedical applicationspor
dc.subjectTherapeutic deep eutectic solventspor
dc.titleA comparison between pure active pharmaceutical ingredients and therapeutic deep eutectic solvents: solubility and permeability studiespor
dc.typearticle-
dc.peerreviewedyespor
dc.commentshttp://3bs.uminho.pt/node/19008por
oaire.citationStartPage296por
oaire.citationEndPage304por
oaire.citationVolume114por
dc.date.updated2017-09-25T15:00:29Z-
dc.identifier.eissn1873-3441por
dc.identifier.doi10.1016/j.ejpb.2017.02.003por
dc.identifier.pmid28189620por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersionpor
dc.subject.wosScience & Technologypor
sdum.journalEuropean Journal Of Pharmaceutics And Biopharmaceuticspor
Aparece nas coleções:3B’s - Artigos em revistas/Papers in scientific journals

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
19008-EurJPharmBiopharm - permeability THEDES.pdf929,2 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID